WVE - Wave Life Sciences GAAP EPS of -$0.42 beats by $0.08 revenue of $0.29M misses by $5.11M
- Wave Life Sciences press release ( NASDAQ: WVE ): Q3 GAAP EPS of -$0.42 beats by $0.08 .
- Revenue of $0.29M (-99.2% Y/Y) misses by $5.11M .
- As of September 30, 2022, Wave had $122.0 million in cash, cash equivalents and short-term investments.
For further details see:
Wave Life Sciences GAAP EPS of -$0.42 beats by $0.08, revenue of $0.29M misses by $5.11M